UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Qualification
Date Qualified: December 13, 2021 4:00 P.M.
Form: 1-A
 
CIK: 0000849636
Company Name: RespireRx Pharmaceuticals Inc.
File Number: 024-11602